CF Industries Holdings, Inc. to Participate in Upcoming Investor Conference

DEERFIELD, Ill.--(BUSINESS WIRE)-- CF Industries Holdings, Inc. (NYSE: CF) today announced that the company will present at 12:15 p.m. ET on Tuesday, November 27, 2018, at the Citi Basic Materials Conference.

Investors who wish to access the live conference webcast should visit the Investor Relations section of the company’s website at www.cfindustries.com. A replay of the webcast will be available on the CF Industries Holdings, Inc. website until March 31, 2019.

About CF Industries Holdings, Inc.

CF Industries is a leading global fertilizer and chemical company with outstanding operational capabilities and a highly cost-advantaged production and distribution platform. Our 3,000 employees operate world-class manufacturing complexes in Canada, the United Kingdom and the United States. We serve our customers in North America through an unparalleled production, storage, transportation and distribution network. We also reach a global customer base with exports from our Donaldsonville, Louisiana, plant, the world’s largest and most flexible nitrogen complex. Additionally, we move product to international destinations from our Verdigris, Oklahoma, facility; our Yazoo City, Mississippi, facility; our Billingham and Ince facilities in the United Kingdom; and from a joint venture ammonia facility in the Republic of Trinidad and Tobago in which we own a 50 percent interest. CF Industries routinely posts investor announcements and additional information on the company’s website at www.cfindustries.com and encourages those interested in the company to check there frequently.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181120005714/en/

CF Industries Holdings, Inc.
Media
Chris Close
Director, Corporate Communications
847-405-2542 – [email protected]
or
Investors
Martin Jarosick
Vice President, Investor Relations
847-405-2045 – [email protected]

Source: CF Industries Holdings, Inc.

You May Also Be Interested In

• Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
• InterSystems Asia READY 2026 to Showcase AI-Ready Healthcare
• World's First Autonomous Humanoid Tennis Match: GALBOT Robots Complete 100+ Consecutive Rallies